QAQorri’ Aina

Qorri’ Aina

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qorri’ Aina has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Deteksi Dini Autism Spectrum Disorder pada Balita di Kota Probolinggo

    by Prastiya Indra Gunawan, Riza Noviandi, Sunny Mariana Samosir, Firyal Nadiah Rahmah, Tioky Sutjonong, Qorri 'AIna, Shofia Ihtasya, Syania Mega Octariandra, Yunias Setiawati

    Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder that manifests in early childhood, characterized by difficulties in communication, social interaction, and restricted, repetitive patterns of behavior and interests. Symptoms of ASD can be identified as early as 6 to 18 months of age, with initial signs often involving impairments in cognitive and social functioning. Awareness of early symptoms, early detection, and timely intervention significantly influence developmental outcomes. This activity aimed to provide information regarding the early signs of ASD, screening methods, and diagnostic assessment using DSM-5 criteria, particularly for the community in Probolinggo. The methods included disseminating information through online media and directing parents to complete the M-CHAT screening questionnaire. M-CHAT results were then used as the basis for comprehensive interviews and clinical evaluations conducted according to DSM-5 criteria. A total of 25 participants completed the M-CHAT, and 16 attended the follow-up clinical assessments. The findings indicated that speech delay was the most common concern among parents related to the potential presence of ASD in their children. Among the children screened, 10 (50.5%) were categorized as low risk, 5 (31.24%) as medium risk, and 1 (6.25%) as high risk. Following thorough assessments and DSM-5-based evaluations, 2 children (12.5%) were diagnosed with atypical ASD, 12 children (75%) with speech delay, and 2 children (12.5%) with other conditions. These results highlight that not all speech delays are indicative of ASD; however, parental awareness regarding early signs of ASD was adequate to support screening and further evaluation.

  • Open Access

    Vitamin D supplementation decrease asthma exacerbations in children: a systematic review and meta-analysis of randomized controlled trials

    by Katherine Fedora, Retno Asih Setyoningrum, Qorri’ Aina, Laili Nur Rosyidah, Nur Lailatun Ni’mAh, Feelin Fatwa Titiharja

    Observational studies have linked low vitamin D (VD) levels to increased asthma attacks in children. Subsequent meta-analyses of adults and children revealed that VD treatment might benefit asthmatic patients by reducing the incidence of exacerbations. Therefore, this review aims to analyze the effects of VD supplementation in reducing asthma exacerbations in children. Published reports from PubMed, Cochrane, and Google Scholar were systematically searched until April 2023. The study protocol was registered in the PROSPERO database CRD42023411796. Randomized controlled trial studies were included in this review. Meta-analysis was performed using Cochrane RevMan 5.1 and presented with 95% confidence intervals (CIs). Ten relevant studies enrolled 1243 asthmatic children (631 children receiving vitamin D3 supplementation, 612 children receiving placebo) were included in this review. Our pooled analysis found that VD supplementation had a significant effect on lowering the total number of asthma exacerbations (RR 0.62; 95% CI: 0.44, 0.87; p = 0.01). Subgroup analysis revealed that a daily dose of VD given based on standard daily dose recommendation had a significant improvement on asthma exacerbations [(RR 0.41; 95% CI: 0,18, 0,92; p = 0.03). Vitamin D supplementation can lower the occurrence of exacerbations in children with asthma, along with the improvement of FEV1.


  • Open Access

    The Role of Telemedicine in Type 1 Diabetes Children during COVID-19 Pandemic Era: A Systematic Review and Meta-analysis

    by Nur Rochmah, Farahdina Farahdina, Wika Yuli Deakandi, Qurrota Ayuni Novia Putri, Tyas Maslakhatien Nuzula, Katherine Fedora, Qorri ‘aIna, Muhammad Faizi

    BACKGROUND: The COVID-19 pandemic determined a profound impact on the routine follow-up of type 1 diabetes (T1D) children. Telemedicine represents a critical tool to guarantee regular care for these patients in this form. AIM: The purpose of this study was to assess the impact of telemedicine programs during the COVID-19 pandemic era on T1D children. PATIENTS AND METHODS: Studies from PubMed, Cochrane, and Directory of Open Access Journals from December 2021, to February 18, 2022, were conducted to calculate the pooled mean difference using either a random or fixed-effect model in Review Manager version 5.3. Our study has applied to ensure that our procedures, including record collection, extraction of data, quality evaluation, and statistical analysis, adhere to the Preferred Reporting Items for Systematic Examination and Meta-Analysis guidelines. RESULTS: Three articles relevant to the current study (436 children). Our pooled analysis found that there was an impact of telemedicine in reducing the HbA1c (mean diff: 5.64 [95% confidence interval (CI) 3.71–7.57], p < 0.00001). However, the physical activity was not affected by the telemedicine program (mean diff: −37.25 [95% CI −317.53–243.02], p = 0.79). CONCLUSION: Our findings suggest that telemedicine has a role in T1D children controlling HbA1c during the COVID-19 pandemic. Meanwhile, telehealth has emerged as a promising alternate mode of health-care delivery. Its utility during the pandemic warrants further investigation.